Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.37 USD | -0.88% | -6.65% | -41.49% |
May. 13 | Transcript : Journey Medical Corporation, Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Journey Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 56.82M | Sales 2025 * | 80.37M | Capitalization | 67.31M |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | -4M | EV / Sales 2024 * | 1.18 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.84 x |
P/E ratio 2024 * |
-3.6
x | P/E ratio 2025 * |
-14
x | Employees | 41 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.62% |
Latest transcript on Journey Medical Corporation
1 day | -0.88% | ||
1 week | -6.65% | ||
Current month | -8.67% | ||
1 month | -3.16% | ||
3 months | -10.37% | ||
6 months | -21.81% | ||
Current year | -41.49% |
Managers | Title | Age | Since |
---|---|---|---|
Claude Maraoui
FOU | Founder | 57 | 14-09-30 |
Joseph Benesch
DFI | Director of Finance/CFO | 57 | 21-10-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 14-09-30 | |
Neil Herskowitz
BRD | Director/Board Member | 67 | 20-12-31 |
Miranda Toledano
BRD | Director/Board Member | 47 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 3.37 | -0.88% | 105,858 |
24-05-20 | 3.4 | -1.45% | 53,153 |
24-05-17 | 3.45 | -4.70% | 67,276 |
24-05-16 | 3.62 | +0.84% | 26,184 |
24-05-15 | 3.59 | -0.55% | 61,077 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.49% | 67.31M | |
+37.78% | 723B | |
+30.47% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.47% | 244B | |
-4.58% | 208B | |
+10.07% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- DERM Stock